Revistin, a substance that strongly inhibits the reverse transcriptase activity of murine leukemia virus in our screening system, was obtained from a cultured broth of a soil streptomyces which was closely related to Streptonryces filipinensis. The assay method for the activity was based on the inhibition by a test material of the incorporation of 3H-dTMP into DNA synthesized by the reverse transcriptase of an oncogenic RNA virus. Crude revistin was isolated by serial procedures of salting out with ammonium sulfate and precipitation with cetylpyridinium chloride. The crude material showed neither antibacterial nor antifungal activity. It exhibited inhibition against splenomegaly in mice caused by RAUSCHER leukemia virus infection.
Revistin, a substance that strongly inhibits the reverse transcriptase activity of murine leukemia virus in our screening system, was obtained from a cultured broth of a soil streptomyces which was closely related to Streptonryces filipinensis. The assay method for the activity was based on the inhibition by a test material of the incorporation of 3H-dTMP into DNA synthesized by the reverse transcriptase of an oncogenic RNA virus. Crude revistin was isolated by serial procedures of salting out with ammonium sulfate and precipitation with cetylpyridinium chloride. The crude material showed neither antibacterial nor antifungal activity. It exhibited inhibition against splenomegaly in mice caused by RAUSCHER leukemia virus infection. Materials and Methods
Screening and assay
Murine leukemia virus (MLV), one of the most typical oncogenic RNA virus, was used as the enzyme for screening purposes. MLV (AKR-3T3) (Electro-Nucleonics Lab., Bethesda , Md.) was purified by linear sucrose gradient centrifugation (20-55 %, in 0.01 M Tris-HCl, 0.1 M NaCl, 0.001 M EDTA, pH 7.2) at 120,000 x g for 4 hours in a Spinco SW65LTi rotor, followed by dialysis of the resultant virus fraction against 0.01 M Tris buffer (pH 8.1) overnight. The protein concentration of the virus suspension was determined by LOWRY's method. Synthetic copolymer, poly(dT)poly(A) (purchased from Miles Lab. Inc.) was employed as a template. 3H -(Methyl-)thymidine triphosphate (specific activity 26.1-r 30 ci/m mol) was purchased from (1) Sucrose-nitrate agar (WAKSMAN mediums8) No. 1, incubated at 27'C): Good growth with light yellow (lea) reverse; pearl (2ba) powdery aerial mycelium with exudate; butter yellow (2ga) diffusible pigment.
The color of this pigment was not changed by addition of 0.05 N NaOH or 0.05 N HCl.
(2) Glucose-asparagine agar (WAKSMAN medium No. 2, incubated at 27°C): Good growth with light spice brown (41g) reverse; ivory tint (2cb) to yellowish gray (2dc) aerial mycelium; light yellow (lea) diffusible pigment. (8) Synthetic nitrate broth10) (incubated at 27°C): Light yellow (lea) soluble pigment which was changed to sunlight yellow (l1/2ga) with 0.05 N NaOH and recovered with acid.
Physiological characteristics:
Positive hydrolysis of starch on inorganic salts-starch agar; no nitrate reduction to nitrite in nitrate nutrient broth and synthetic nitrate broth; melanine pigment production in tyrosine agar, glucose-peptone gelatin and tryptone-yeast extract broth; weak proteolytic action on skimmed milk and gelatin medium; no coagulation of milk; hydrogen sulfide production in proteose peptone-glucose agar (detected by lead acetate paper); positive utilization of n-glucose, Streptomyces filipinensis: Yellowish gray (3dc) to silver gray (3fe) aerial mycelium on yeast extract-malt extract agar, oatmeal agar, inorganic salts-starch agar and glucose-asparagine agar; light yellowish brown reverse side color was much lighter than that of strain E397-1; no diffusible pigment or only trace of pale yellow pigment produced on various media including synthetic nitrate broth.
Streptomyces durhamensis: Color of aerial mycelium, reverse side color of growth and diffusible pigment were almost the same as those of S. filipinensis strain ISP 5112; positive coagulation of milk.
Streptomyces griseochromogenes: Color of aerial mycelium, reverse side color and diffusible pigment on various media were very similar to those of S. filipinensis and S. durhamensis; positive nitrate reduction to nitrite; thin, pearl (3ba) aerial mycelium on nutrient agar. Streptomyces alanosinicus: Loose or tight spirals with more than 5 turns on glycerolasparagine agar; flesh pink (4ca) aerial mycelium on oatmeal agar and inorganic salts-starch agar; no diffusible pigment or slightly pale orange yellow diffusible pigment on various media. Strain E397-1 was most closely related to Streptomyces filipinensis, but it was distinguished from this species in the production of a pH-sensitive pigment on synthetic nitrate broth, the pigment which colored the reverse side of growth and diffused into media, and the color of aerial mycelium.
Besides, the strain E397-1 produced no antimicrobial substances, while Streptomyces filipinensis produced filipin, an antifungal polyene antibiotic.
3. Production of Revistin The strain E397-1 was grown in 100 ml of a medium placed in 500 ml SAKAGUCHI flasks and shake-cultured at 27°C for 4 days. Highest yields ware obtained in the three following media: glycerol 2.5 %, polypeptone 1.0 %, yeast extract 0.2 %, CaCO3 0.6 % ; glucose 2.5 % instead of glycerol in the previous medium; and glycerol 2.0 %, soybean meal 1.5 , K2HPO4 0.1 %. All media were adjusted to pH 6.8. Culture filtrates diluted 80-100 times showed 50 % inhibition.
Extraction of Revistin
Three liters of fermented broth were centrifuged at 10,000 rpm for 10 minutes and to the gently stirred supernatant ammonium sulfate was added to saturation at 4°C and this was kept overnight in a cold room. The precipitate was collected by centrifugation at 10,000 rpm for brown, revistin powder was obtained.
Activity of the Crude Revistin
Cetylpyridinium chloride which might contaminate the crude revistin did not show the inhibition of reverse transcriptase at 100 ,ug/ml. The activity of the crude revistin was heatstable and not reduced by heating at 100°C for 20 minues at pH 3-10. Electrophoresis, gel filtration, ultracentrifugation and ultrafiltration suggested that revistin would be an acidic highmolecular substance.
The crude powder exhibited strong inhibition of reverse transcriptase -50% inhibition at 2 .3,ug/ml. This concentration is much lower than that necessary with known antibiotics e.g. 2001 Cg/ml of N-demethylrifamycin was required for 50 % inhibition. The powder did not show any antimicrobial activity when tested at 10 mg/ml against Staphylococcus aureus ATCC 6538P, Bacillus subtilis ATCC 6633, Candida albicans 3147, Trichophyton mentagrophytes 640, Pseudomonas aeruginosa, Escherichia coli NIHJ, Mycobacterium smegmatis ATCC 607, Piricularia oryzae and Xanthomonas citri. No toxicity was observed in mice by intravenous injection of 500 mg/kg of the crude powder. Chemical properties will be reported in another paper.
Effect of Revistin on RAUSCHER Leukemia Virus-infected Mice
Because revistin was so highly active against reverse transcriptase activity of murine leukemia virus, we examined the therapeutic effect of crude revistin on RAUSCHER leukemia virus (RLV) infection in mice. RLV induces a dual type of disease in 90-100 % of mice of different strains: the disease is characterized by splenomegaly and rapid and extreme prolifieration of predominantly erythrocytic and leukocytic elements at the early stage following parenteral inoculation of the virus and by leukemia which appears in survivor mice about 35 days after the infection16,17). BORDEN et al.7) described that the splenomegaly serves as a quantitative parameter of chemotherapeutic effect. Male ddY mice, 5 weeks old and weighing about 20g, were intraperitoneally infected with RLV, receiving a dose of 0.5 ml of 640Xdiluted virus suspension. These animals were arbitrarily divided into groups as follows: In group I, daily intraperitoneal injection of revistin was initiated on the day of infection and continued once a day for 4 days (day 0 through day 3) (see Table 1 ). In group II, the same treatment was started on day 5 and continued for 5 days (day 5 through day 9). Control groups included animals infected with virus but not treated with revistin, and noninfected animals with and without revistin administration. Each experimental group consisted of eighteen mice. Twelve days after the infection, all the mice were killed and the spleens were taken and the weight was examined. The result is shown in Table 1 .
Inhibition by the crude revistin treatment of the splenomegaly was estimated by calculation to which revistin was administrated, mice infected with virus but not receiving revistin and noninfected aminals with no revistin administration, respectively. As seen in Table 1 , revistin inhibited the splenic enlargement due to RLV infection in the case of delayed therapy (group II), showing the inhibition rates of 89.8 % and 51.2 % at dosages of 4 mg and 2 mg/mouse/day, respectively. Delayed treatment produced inhibition, whereas the early treatment did not. This was confirmed in a second similar experiment.
The difference between the effect of the delayed treatment and that of the early treatment may be due to the more rapid rate of virus multiplication during 5-9 days after the infection than that immediately after the infection. The therapy at a daily dose of 4 mg/mouse gave stronger effect than at 8 mg/mouse and suggests that it may be in a range of the most suitable dose for the treatment. 
